Clinical Trials Innovation Summit 2022

Clinical Trials
Innovation Summit 2022

28 JUNE 2022 | ROCHE BUILDING 1 | BASEL

PRESENTED BY

"TO THRIVE AS A FIELD, DIGITAL MEDICINE REQUIRES AN UNPRECEDENTED LEVEL OF INTERDISCIPLINARY COLLABORATION. FROM REGULATORS TO WHITE-HAT HACKERS, ETHICISTS TO ENGINEERS, AND CLINICIANS TO CITIZEN SCIENTISTS, NEW COOPERATIVE NETWORKS MUST EMERGE TO ENSURE THAT DIGITAL MEDICINE REALIZES ITS FULL POTENTIAL TO IMPROVE HUMAN HEALTH." (DIGITAL MEDICINE SOCIETY)

Building off of recent advancements in the field, PanAgora Pharma and Roche are collaborating to build the Clinical Trials Innovation Summit 2022. The conference agenda focuses on how life sciences organizations are improving clinical trial design, recruitment, and retention, while collecting better data, saving on trial costs, and ultimately delivering a better patient experience. Join 25+ speakers and 250+ senior-level clinical research & decentralized clinical trials leaders this June at Roche Headquarters in Basel!

Key Topics Include:
• Human Centric Health Innovation
• Driving Innovation in Decentralized Clinical Trials
• Regulatory Process & Governance in Decentralized Clinical Trials
• Technologies Improving the DCT Patient Experience
• Standards and Technologies Enabling Data Sharing and Integration
• Accelerating Research by Empowering Patients
• Lab of the Future: Longevity

Location

Roche Building 1
Basel, Switzerland

Date & Time

28 June 2022
09:00-18:00 Local Time (GMT+2)

HOST SPONSOR

CORE THEMES:

1. Human-Centered Health Innovation
2. Driving Innovation in Decentralized Clinical Trials
3. Technologies Improving the Clinical Trials Patient Experience
4. Data Sharing and Integration: Standards & Technology

Conference Schedule

28 June 2022

09:00 - 09:05

Opening Remarks from the Conference Chair

Matthias Ganniger, Head of Business Technology, pRED, Roche

09:05 - 09:15

Welcome Address

Scott Oloff, SVP of Data and Analytics, Roche

09:15 - 09:40

Panel: Human-Centric Clinical Innovations

Lea Proulx, Patient Voice Partner, Roche
Adama Ibrahim, Director, Digital Innovation, Novartis
Peter Van Dael, SVP, Nutrition Science and Advocacy, DSM Nutritional Products

Moderator: Steven Bourke, Founder, PersonalPulse

09:40 - 10:05

Panel: Diversity, Equity and Inclusion in Clinical Trials

Panelists TBA

10:05 - 10:25

Use Case: MyStudyWindow - Lessons in Patient-Centricity

Sonia Houston Pichardo, Business Lead, MyStudyWindow, Boehringer Ingelheim

10:25 - 10:45

Use Case: data42 - A Single Source of Healthcare R&D Data

Peter Speyer, Head of Customer Success, data42, Novartis

10:45 - 11:05

Networking Break

11:05 - 11:25

Where are we with Decentralized Clinical Trials (DCTs) - A Sponsor’s review of the current regulatory landscape and potential barriers to scale

• A review of where the industry stands today in regards to Decentralized Clinical Trial (DCT) guidances, and why these are so important
• A discussion of Regulatory Barriers that may be slowing wider scale adoption

Scott Askin, Global Program Regulatory Director for Innovation, Novartis

11:25 - 11:45

Integrating Real-World Patient-Data Streams in Decentralized Trials

Speaker TBA

11:45 - 12:05

Use Case: Decentralized Trials – Beyond the Glossy Sales Slides

Joachim Luithle, VP, Head Clinical Development Operations, Bayer

12:05 - 12:30

Panel: Leading Innovation in Decentralized Clinical Trials

Hadas Lewy, Head of Digital Health Ventures, Holon Institute of Technology
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research
Jeremy Wyatt, Chief Executive Officer, ActiGraph

Moderator: Dan Karlin, Chief Medical Officer, MindMed

12:30 - 13:30

Networking Lunch

13:30 - 13:55

Panel: Technologies Improving the Clinical Trials Patient Experience

Uta Sweere, Clinical Program Leader, Roche
Gerald Randolph, pRED Data & Analytics, Roche (TBC)
Michael Rebhan, Associate Director, Precision Medicine, Novartis
Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata

13:55 - 14:15

Use Case: PSS - Predictive Site Selection

Data-driven selection of sites to increase inclusiveness & diversity of our trials.

Eric Malek, pRED Clinical Operations Data Scientist, Roche
Speaker TBA, Roche

14:15 - 14:35

Presentation TBA

Chris Benko, Chief Executive Officer, Koneksa Health

14:35 - 14:55

Use Case: Empowering Patients by Leveraging Blockchain Technology in a Clinical Trial

Baldwin Mak, Digital Expert, Dept. of Clinical Operations, Boehringer Ingelheim

14:55 - 15:20

Panel: Pushing the Boundaries in a Regulated Environment

Scott Askin, Global Program Regulatory Director for Innovation, Novartis
Additional Panelists TBA

Moderator: Lada Leyens, Regulatory Program Director, Roche

15:20 - 15:45

Networking Break

15:45 - 16:10

Panel: Data Sharing and Integration: Standards and Technology

Martin Romacker, Head of Terminology Services, Roche
Astrid Kiermeier PHC Leader, Roche (tbc)
Peter Speyer, Head of Customer Success, data42, Novartis

16:10 - 16:30

Use Case: Digital Protocol Design

Data-driven design of clinical trials with recruitability and reduction of patient (and site) burden in mind.

Arianna Secco, Data Scientist, Roche
Todd Georgieff, External Engagement and Content Standards Lead, Roche

16:30 - 16:50

Implementing Digital Medicine Approaches to Transform Clinical Trials

Use Case: Novel biomarker detection technologies in oncology and patient-centric companion therapeutics

David Kiger, GVP, Digital Therapeutics, Biofourmis

16:50 - 17:15

Panel: Patient Perspectives in Clinical Trials

Hear from patients how was their experience as clinical trials participants, what tools and support can help improve engagement and create a sense of “belonging” when participating in a clinical trials.

Steve Bourke, Founder, PersonalPulse
Amri Johnson, Chief Executive Officer, Inclusion Wins
Additional Panelists TBA

Moderator: Lea Proulx, Patient Voice Partner, Roche

17:15 - 17:40

Closing Panel: The Future of Clinical Innovation - What's Next?

James Donohue, Trial Innovation Partner, Early Research & Development ClinOps, Roche
Dudley Tabakin, Chief Executive Officer, VivoSense
Disa Lee Choun, Head of Integrated Clinical and Operational Analytics, Janssen

17:40 - 19:00

APÉRO NETWORKING EVENT

Speakers